Correction: NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer

Saved in:
Bibliographic Details
Published inBreast cancer research : BCR Vol. 26; no. 1; p. 83
Main Authors Jacobs, Samuel A, Wang, Ying, Abraham, Jame, Feng, Huichen, Montero, Alberto J, Lipchik, Corey, Finnigan, Melanie, Jankowitz, Rachel C, Salkeni, Mohamad A, Maley, Sai K, Puhalla, Shannon L, Piette, Fanny, Quinn, Katie, Chang, Kyle, Nagy, Rebecca J, Allegra, Carmen J, Vehec, Kelly, Wolmark, Norman, Lucas, Peter C, Srinivasan, Ashok, Pogue-Geile, Katherine L
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 24.05.2024
BioMed Central
BMC
Online AccessGet full text

Cover

More Information
Bibliography:correction
SourceType-Other Sources-1
content type line 63
ObjectType-Correction/Retraction-1
ISSN:1465-542X
1465-5411
1465-542X
DOI:10.1186/s13058-024-01833-6